Abstract
Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1200/jco.2014.32.15_suppl.2539
Copy DOIJournal: Journal of Clinical Oncology | Publication Date: May 20, 2014 |
Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
Join us for a 30 min session where you can share your feedback and ask us any queries you have